| Nanoparticle characterization: state of the art, challenges, and emerging technologies EJ Cho, H Holback, KC Liu, SA Abouelmagd, J Park, Y Yeo Molecular pharmaceutics 10 (6), 2093-2110, 2013 | 456 | 2013 |
| Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers J Park, TF Brust, HJ Lee, SC Lee, VJ Watts, Y Yeo ACS nano 8 (4), 3347-3356, 2014 | 406 | 2014 |
| Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery Z Amoozgar, J Park, Q Lin, Y Yeo Molecular pharmaceutics 9 (5), 1262-1270, 2012 | 178 | 2012 |
| Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors H Hyun, J Park, K Willis, JE Park, LT Lyle, W Lee, Y Yeo Biomaterials 180, 206-224, 2018 | 121 | 2018 |
| Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines J Park, J Park, Y Pei, J Xu, Y Yeo Advanced drug delivery reviews 104, 93-109, 2016 | 96 | 2016 |
| Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries TA Rickett, Z Amoozgar, CA Tuchek, J Park, Y Yeo, R Shi Biomacromolecules 12 (1), 57-65, 2011 | 96 | 2011 |
| Albumin-coated nanocrystals for carrier-free delivery of paclitaxel J Park, B Sun, Y Yeo Journal of Controlled Release 263, 90-101, 2017 | 81 | 2017 |
| Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles E Gullotti, J Park, Y Yeo Pharmaceutical research 30, 1956-1967, 2013 | 76 | 2013 |
| Sustained delivery of carfilzomib by tannic acid-based nanocapsules helps develop antitumor immunity MS Taha, GM Cresswell, J Park, W Lee, TL Ratliff, Y Yeo Nano letters 19 (11), 8333-8341, 2019 | 55 | 2019 |
| A Comparative In Vivo Study of Albumin‐Coated Paclitaxel Nanocrystals and Abraxane J Park, JE Park, VE Hedrick, KV Wood, C Bonham, W Lee, Y Yeo Small 14 (16), 1703670, 2018 | 53 | 2018 |
| Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive Z Amoozgar, T Rickett, J Park, C Tuchek, R Shi, Y Yeo Acta biomaterialia 8 (5), 1849-1858, 2012 | 53 | 2012 |
| Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation JE Park, J Park, Y Jun, Y Oh, G Ryoo, YS Jeong, HH Gadalla, JS Min, ... Journal of controlled release 302, 148-159, 2019 | 44 | 2019 |
| Enhancing docetaxel delivery to multidrug-resistant cancer cells with albumin-coated nanocrystals SF Gad, J Park, JE Park, GN Fetih, SS Tous, W Lee, Y Yeo Molecular pharmaceutics 15 (3), 871-881, 2018 | 31 | 2018 |
| Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors Z Amoozgar, J Park, Q Lin, JH Weidle III, Y Yeo Biomacromolecules 14 (7), 2389-2395, 2013 | 31 | 2013 |
| Magnetophoretic delivery of a tumor-priming agent for chemotherapy of metastatic murine breast cancer J Park, J Park, MA Castanares, DS Collins, Y Yeo Molecular pharmaceutics 16 (5), 1864-1873, 2019 | 10 | 2019 |
| Novel Polymer Micelle and Nanocrystal Formulations for the Proteasome Inhibitor Drug Carfilzomib: Pharmacokinetic and Pharmacodynamic Studies in Human Lung and Breast Cancer Models JE Park, SE Chun, D Reichel, J Park, JS Min, G Ryoo, Y Oh, SK Bae, ... The FASEB Journal 31, 822.6-822.6, 2017 | 3 | 2017 |
| Photo-crosslinkable chitosan hydrogel as a bioadhesive for esophageal stents CG Park, C Shasteen, Z Amoozgar, J Park, SN Kim, JE Lee, MJ Lee, ... Macromolecular Research 23 (9), 882-884, 2015 | 3 | 2015 |
| Carrier-free nanoparticles Y Yeo, J Park, B Sun US Patent 10,398,651, 2019 | | 2019 |
